Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera.
持久的有机化学制剂可有效控制吸血双翅目。
基本信息
- 批准号:10565865
- 负责人:
- 金额:$ 100万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-12 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptionAdultAedesAirAnopheles GenusAreaBacillus thuringiensisBacteriaBacterial Artificial ChromosomesBedsBehaviorBiologicalBloodBlood-Borne PathogensBrazilBreedingChemicalsCollectionConsumptionControl GroupsCulex (Genus)CulicidaeDataDengueDipteraDrynessEnsureEnvironmentExposure toFemaleFloodsFoodFormulationFosteringFriendsGrantHabitatsHomeHuman BitesInfectionIngestionInsecticidesInternationalInterventionInvadedJuvenile HormonesLarvaLeftLifeMalariaMarketingMeasuresMethopreneMosquito ControlMosquito-borne infectious diseaseNamesNatureOrganophosphatesOvipositionPartner in relationshipPenetrationPersonsPest ControlPhasePilot ProjectsPopulationPredispositionProcessRainReadinessRegulationResearchResidual stateResistanceResistance developmentRiskRisk ReductionRunningSafetySalesSedimentation processSemiochemicalsSiteSourceStimulantSurfaceTanzaniaTechnologyTemephosToxinUnited States National Institutes of HealthVariantVectorial capacityWaterWest Nile virusZIKAcommercializationcontrolled releasedesigndisease transmissionefficacy trialeggfeedinglarval controlmalaria mosquitomalaria transmissionmortalitynoveloutbreak controlpreferencepreventprogramspyrethroidresearch and developmentsuccesssuckingtransmission processvectorvector management strategiesvector mosquito
项目摘要
Project Summary:
SPLAT BAC Plus is a unique controlled-release larvicide designed to suppress populations of multiple species of
mosquitoes, such as those that transmit malaria, dengue, and West Nile virus (WNV). This CRP proposal seeks
to establish SPLAT BAC Plus as an effective, economically viable control strategy for use in integrated vector
management (IVM) programs and for control of nuisance mosquitoes around the globe. SPLAT BAC Plus has
several advantages over previous larvicides: 1) It contains a combination of larvicidal agents with different modes
of action: Bacillus thuringiensis israelensis (Bti), B. sphaericus (Bsp) [recently renamed Lysinibacillus
sphaericus]—two bacteria that destroy the gut of mosquitoes that ingest them—and an insect growth regulator
(IGR), such as methoprene or pyriproxyfen, that prevents larvae from developing into adults. This combination
drastically reduces the risk of resistance compared to single-action larvicides. While there are products on the
market combining Bti and Bsp, the inclusion of an IGR in SPLAT BAC Plus will further inhibit the development
of resistance and greatly extend the field life of the larvicide. 2) SPLAT BAC Plus includes components that
promote larval attraction and feeding on the formulation—intensifying their exposure to the Bti, Bsp, and IGR
contained within it—and oviposition attractants (attractants for egg-laying females). As point sources of SPLAT
BAC Plus float at the surface of treated water, these attractants are released into the air, enticing female
mosquitoes to lay their eggs preferentially at that site. 3) SPLAT BAC Plus can be applied to potential larval
habitats under dry conditions ahead of rainfall, a major advantage over most larvicides, which must be applied
shortly after these sites fill with water to catch mosquito larvae at a susceptible stage. 4) Following application,
SPLAT BAC Plus cures and becomes rainfast, becoming activated when the surfaces are submerged for a few
days, detaching and floating to the water's surface and releasing its attractants. After this point, SPLAT BAC Plus
remains buoyant and effective for up to 5 months, considerably longer than the 1–2 week-field life associated
with older Bti/Bsp larvicides. 5) SPLAT BAC Plus contains environmentally safe larvicides and semiochemical
attractants incorporated in an inert matrix composed of food-safe ingredients. To achieve global
commercialization of SPLAT BAC Plus, ISCA Technologies intends to pursue the following Specific Aims: 1)
Obtain the required regulatory approvals to begin sales of SPLAT BAC Plus in the US and begin penetration of
target international markets (e.g., Brazil, Tanzania); 2) Foster consumer support and buy-in via demonstration
trials of SPLAT BAC Plus with targeted distributors of mosquito control products, pest control operators (PCOs),
and mosquito control districts; and 3) Utilize SPLAT BAC Plus to launch a more diversified product line of
mosquito control technologies, designed to conform to the different needs of various mosquito control groups
and consumers, such as varying target species, environmental and safety concerns, and difficulties with
resistance to different control agents.
项目概要:
SPLAT BAC Plus是一种独特的控制释放杀幼虫剂,旨在抑制多个物种的种群。
蚊子,如传播疟疾、登革热和西尼罗河病毒(WNV)的蚊子。该CRP提案旨在
建立SPLAT BAC Plus作为一种有效的、经济上可行的控制策略,用于综合媒介
防治(IVM)计划和控制地球仪周围的讨厌蚊子。SPLAT BAC Plus具有
与以前的杀幼虫剂相比,它具有以下几个优点:1)它含有不同模式的杀幼虫剂组合
苏云金芽孢杆菌(Bacillus thuringiensis israelensis,Bti),B.球形芽孢杆菌(Bsp)[最近改名为赖氨酸芽孢杆菌
sphaericus]--两种破坏蚊子肠道的细菌,以及一种昆虫生长调节剂
(IGR),如烯虫酯或吡丙醚,防止幼虫发育成成虫。这种组合
与单效杀幼虫剂相比,大大降低了抗药性的风险。虽然有产品在
市场结合Bti和Bsp,在SPLAT BAC Plus中包含IGR将进一步抑制发展
并大大延长了杀幼虫剂的田间使用寿命。2)SPLAT BAC Plus包括以下组件,
促进幼虫的吸引力和对制剂的摄食-加强它们对Bti、Bsp和IGR的暴露
其中包含的-和产卵引诱剂(产卵雌性引诱剂)。作为SPLAT的点源
BAC Plus漂浮在处理过的水面上,这些引诱剂被释放到空气中,引诱雌性
蚊子会优先在那里产卵。3)SPLAT BAC Plus可用于潜在幼虫
栖息地在干燥的条件下提前降雨,一个主要的优势,大多数杀幼虫剂,必须适用
不久后,这些地点充满水,以捕捉处于易感阶段的蚊子幼虫。4)在应用之后,
SPLAT BAC Plus固化并固化,当表面浸没几分钟后就会被激活
天,分离和漂浮到水面,并释放其引诱剂。在此之后,SPLAT BAC Plus
保持浮力和有效长达5个月,大大超过1-2周的现场寿命相关
使用老的Bti/Bsp杀幼虫剂。5)SPLAT BAC Plus含有环保的杀幼虫剂和化学信息素
引诱剂掺入由食品安全成分组成的惰性基质中。实现全球
SPLAT BAC Plus的商业化,ISCA技术公司打算追求以下具体目标:1)
获得所需的监管批准,以便开始在美国销售SPLAT BAC Plus,并开始渗透
瞄准国际市场(例如,巴西、坦桑尼亚); 2)通过示范促进消费者的支持和接受
SPLAT BAC Plus与目标蚊子控制产品经销商、害虫控制运营商(PCO)进行试验,
及蚊患防治区;及3)利用SPLAT BAC Plus推出更多元化的产品系列,
灭蚊技术,以配合不同灭蚊团体的不同需要
和消费者,如不同的目标物种,环境和安全问题,以及困难,
对不同控制剂的抗性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Agenor Mafra-Neto其他文献
Agenor Mafra-Neto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Agenor Mafra-Neto', 18)}}的其他基金
Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera.
持久的有机化学制剂可有效控制吸血双翅目。
- 批准号:
10383803 - 财政年份:2017
- 资助金额:
$ 100万 - 项目类别:
Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera
持久的有机化学制剂可有效控制吸血双翅目
- 批准号:
9409577 - 财政年份:2017
- 资助金额:
$ 100万 - 项目类别:
Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera
持久的有机化学制剂可有效控制吸血双翅目
- 批准号:
9527066 - 财政年份:2017
- 资助金额:
$ 100万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 100万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 100万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 100万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 100万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 100万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 100万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Grant-in-Aid for Scientific Research (C)